Profund Advisors LLC Sells 82 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Profund Advisors LLC trimmed its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.6% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 3,039 shares of the company’s stock after selling 82 shares during the quarter. Profund Advisors LLC’s holdings in HCA Healthcare were worth $976,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. FinTrust Capital Advisors LLC grew its position in HCA Healthcare by 26.7% in the fourth quarter. FinTrust Capital Advisors LLC now owns 166 shares of the company’s stock worth $45,000 after acquiring an additional 35 shares in the last quarter. Lake Street Advisors Group LLC boosted its stake in HCA Healthcare by 1.3% in the second quarter. Lake Street Advisors Group LLC now owns 2,732 shares of the company’s stock worth $878,000 after buying an additional 35 shares in the last quarter. Financial Counselors Inc. raised its stake in shares of HCA Healthcare by 1.4% during the first quarter. Financial Counselors Inc. now owns 2,642 shares of the company’s stock worth $881,000 after acquiring an additional 36 shares in the last quarter. Premier Path Wealth Partners LLC grew its holdings in shares of HCA Healthcare by 2.7% during the 2nd quarter. Premier Path Wealth Partners LLC now owns 1,393 shares of the company’s stock valued at $448,000 after purchasing an additional 36 shares during the last quarter. Finally, Westside Investment Management Inc. boosted its position in HCA Healthcare by 14.7% during the second quarter. Westside Investment Management Inc. now owns 289 shares of the company’s stock valued at $93,000 after buying an additional 37 shares during the period. 62.73% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the company. Leerink Partners increased their price objective on HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. Oppenheimer upped their price objective on shares of HCA Healthcare from $345.00 to $390.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. Wells Fargo & Company upped their price target on HCA Healthcare from $315.00 to $365.00 and gave the company an “equal weight” rating in a research report on Tuesday, July 30th. Robert W. Baird initiated coverage on HCA Healthcare in a report on Thursday, May 30th. They set an “outperform” rating and a $396.00 target price for the company. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $392.00 price objective on shares of HCA Healthcare in a report on Monday, August 19th. Five analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $359.89.

Insider Activity

In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of HCA Healthcare stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the transaction, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the sale, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 17,202 shares of company stock valued at $6,407,273. 1.60% of the stock is currently owned by corporate insiders.

HCA Healthcare Stock Up 0.3 %

Shares of HCA opened at $405.71 on Tuesday. The stock has a 50 day moving average price of $372.34 and a 200 day moving average price of $341.21. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. The stock has a market capitalization of $106.26 billion, a price-to-earnings ratio of 20.22, a PEG ratio of 1.46 and a beta of 1.67. HCA Healthcare, Inc. has a one year low of $215.96 and a one year high of $409.42.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The business had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. During the same period last year, the company earned $4.29 EPS. The company’s revenue for the quarter was up 10.3% on a year-over-year basis. Equities research analysts forecast that HCA Healthcare, Inc. will post 22.46 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be given a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.65%. The ex-dividend date is Monday, September 16th. HCA Healthcare’s payout ratio is 13.16%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.